TP53 and cancer: In this study, as a strategy to potentiate the effect of Wip1 overexpression in p53-negative cancers, we have designed a high-throughput screening of the human kinome and analyzed p53-negative cells for kinases, whose inhibition could decrease cisplatin-induced H2AX phosphorylation and at the same time increase tumor cell sensitivity to chemotherapy.